CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,762,780 | -3.8% | 500,101 | +18.6% | 0.37% | +8.5% |
| Q2 2023 | $14,305,397 | -5.7% | 421,615 | +0.0% | 0.34% | -6.1% |
| Q1 2023 | $15,165,714 | -19.3% | 421,504 | 0.0% | 0.36% | -19.9% |
| Q4 2022 | $18,786,433 | +58.5% | 421,504 | -0.0% | 0.45% | +47.7% |
| Q3 2022 | $11,851,000 | +31.0% | 421,604 | +25.7% | 0.31% | +16.3% |
| Q2 2022 | $9,044,000 | +172.8% | 335,477 | +244.7% | 0.26% | +216.9% |
| Q1 2022 | $3,315,000 | – | 97,317 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |